22 Results for "

Compound 52

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "Compound 52" in MCE Product Catalog:

17
17 Cited Publications
Art. -Nr.: HY-15154
CAS. Nr.: 212779-48-1
Reinheit:  99.88%
Synonyms: Compound 52
Target:  

CDK

Forschungsgebiete:  

Cancer

NG 52 is a potent, cell-permeable, selective, ATP-compatible and orally active Cdc28p and Pho85p kinase inhibitor with IC50s of 7 μM and 2 μM, respectively. NG 52 also inhibits the activity of phosphoglycerate kinase 1 (PGK1) with an IC50 of 2.5 μM. NG 52 is inactive against yeast kinases Kin28p, Srb10, and Cak1p .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-139092
CAS. Nr.: 1332184-63-0
Reinheit:  98.04%
Target:  

Interleukin Related

Forschungsgebiete:  

Infection Cancer

IL-4-inhibitor-1 (compound 52) is an IL-4 inhibitor, with an EC50 of 1.81 µM .
loading...
    loading...
Art. -Nr.: HY-150029
CAS. Nr.: 2772655-86-2
Reinheit:  99.83%
Target:  

Cannabinoid Receptor

Forschungsgebiete:  

Neurological Disease

CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist. CB1/2 agonist 3 acts on hCB1 and hCB2 with Ki values of 5.9 nM and 3.5 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-151243
CAS. Nr.: 1964517-04-1
Target:  

Lactate Dehydrogenase

Forschungsgebiete:  

Cancer

NCATS-SM1441 (compound 52) is a lactate dehydrogenase (LDH) inhibitor (IC50=40 nM). By inhibiting the activity of LDH, NCATS-SM1441 is able to reduce the production of lactic acid in cancer cells, helping to slow or stop the proliferation of cancer cells. NCATS-SM1441 can be used to study cancer metabolism .
loading...
    loading...
Art. -Nr.: HY-143604
CAS. Nr.: 2648551-72-6
Target:  

Ras

Forschungsgebiete:  

Cancer

KRAS G12D inhibitor 11 is a potent inhibitor of KRAS G12D. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12D inhibitor 11 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 52) .
loading...
    loading...
Art. -Nr.: HY-15154R
CAS. Nr.: 212779-48-1
Synonyms: Compound 52 (Standard)
Target:  

CDK Reference Standards

Forschungsgebiete:  

Cancer

NG 52 (Standard) is the analytical standard of NG 52. This product is intended for research and analytical applications. NG 52 is a potent, cell-permeable, selective, ATP-compatible and orally active Cdc28p and Pho85p kinase inhibitor with IC50s of 7 μM and 2 μM, respectively. NG 52 also inhibits the activity of phosphoglycerate kinase 1 (PGK1) with an IC50 of 2.5 μM. NG 52 is inactive against yeast kinases Kin28p, Srb10, and Cak1p .
loading...
    loading...
Art. -Nr.: HY-151514
CAS. Nr.: 313981-44-1
Reinheit:  99.76%
Target:  

Bacterial

Forschungsgebiete:  

Infection

Antituberculosis agent-5 (compound 52) is a nitrofuranylamide derivative, inhibits M. tuberculosis UDP-Gal mutase. Antituberculosis agent-5 inhibits Glf activity with an IC50 value of 99 μM/mL and resists tuberculosis (TB) with a MIC value of 1.6 μg/mL .
loading...
    loading...
Art. -Nr.: HY-175507
Target:  

Parasite TRP Channel

Forschungsgebiete:  

Infection

TRPMPZQ-IN-1 (Compound 52) is a TRPMPZQ inhibitor, with an EC50 of 0.38 μM against TRPMPZQ from Spirometra erinaceieuropaei. TRPMPZQ-IN-1 exhibits antiparasitic activity, showing an EC50 of 4.3 μM against Echinococcus multilocularis. TRPMPZQ-IN-1 can be used in antiparasitic research .
loading...
    loading...
Art. -Nr.: HY-175867
Target:  

PROTACs SWI/SNF Complex

Forschungsgebiete:  

Cancer

PROTAC SMARCA2 degrader-34 (compound 52) is a selective SMARCA2 PROTAC degrader (DC50 in HeLa cell: < 0.1 μM for SMARCA2, > 1 μM for SMARCA4). PROTAC SMARCA2 degrader-34 can be used for study of cancer. (Pink: SMARCA2 ligand (HY-178414) ; Blue: E3 ligand (HY-168055) ; Black: linker) .
loading...
    loading...
Art. -Nr.: HY-155425
CAS. Nr.: 1313602-99-1
Target:  

ICMT

Forschungsgebiete:  

Cancer

ICMT-IN-17 (compound 52) is an inhibitor of ICMT (IC50=0.38 μM) .
loading...
    loading...
Art. -Nr.: HY-157578
CAS. Nr.: 1018480-97-1
Target:  

COX

Forschungsgebiete:  

Inflammation/Immunology

COX-2-IN-38 (compound 52*) is a potent inhibitor of COX-2, with the IC50 value of 79.4 nM .
loading...
    loading...
Art. -Nr.: HY-162560
Target:  

LXR

Forschungsgebiete:  

Cancer

Antitumor agent-162 (compound 52a) is a potent and orally active antitumor agent. Antitumor agent-162 shows cytotoxicity .
loading...
    loading...
Art. -Nr.: HY-161625
CAS. Nr.: 2950243-05-5
Target:  

Potassium Channel

Forschungsgebiete:  

Neurological Disease

Kv7.2 modulator 2 (compound 52) is a Kv7.2 channel modulator and can be used for study of epilepsy .
loading...
    loading...
Art. -Nr.: HY-161417
CAS. Nr.: 2747216-27-7
Target:  

LIM Kinase (LIMK)

Forschungsgebiete:  

Cancer

LIMK-IN-2 (Compound 52) is an LIMK inhibitor. LIMK-IN-2 can suppress the cell migration of osteosarcoma and cervical cancer cells, demonstrating potential anti-angiogenic activity .
loading...
    loading...
Art. -Nr.: HY-169303
CAS. Nr.: 3049339-96-7
Target:  

GPR35

Forschungsgebiete:  

Inflammation/Immunology

Gpr35 modulator 2 (compound 52) is a GPR35 modulator. Gpr35 modulator 2 can be used for the study of a various GPR35-related disorders .
loading...
    loading...
Art. -Nr.: HY-162442
Target:  

Ras

Forschungsgebiete:  

Cancer

pan-KRAS-IN-9 (Compound 52) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.24 and 0.30 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-119724
CAS. Nr.: 1942919-63-2
Target:  

BCRP

Forschungsgebiete:  

Cancer

ABCG2-IN-3 (Compound 52) is a selective inhibitor for breast cancer resistance protein (ABCG2), with an IC50 of 0.238 µM. ABCG2-IN-3 reverses the ABCG2-mediated resistance toward SN-38 and inhibit the ATPase activity .
loading...
    loading...
Art. -Nr.: HY-112880
CAS. Nr.: 1951464-78-0
c-(2'FdAMP-2'FdIMP) (Compound 52),a derivative of cAIMP (HY-134375), is a cyclic dinucleotide (CDN). c-(2'FdAMP-2'FdIMP) is a STING activator and significantly induce STING-dependent IRF and NF-κB pathway signaling. c-(2'FdAMP-2'FdIMP) can be used for STING-based immunotherapy, such as cancers and infectious diseases research .
loading...
    loading...
Art. -Nr.: HY-148449
CAS. Nr.: 1402931-66-1
Forschungsgebiete:  

Cancer

eIF4A3-IN-15 (compound 52) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-15 interferes the assembling of eIF4F translation complex with EC50s of 11, 700 and 120 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-15 can be used for the research of human cancer pathogenesis .
loading...
    loading...
Art. -Nr.: HY-176996
CAS. Nr.: 1136839-60-5
Target:  

DNA/RNA Synthesis

Forschungsgebiete:  

Cancer

Ape1/Ref-1 redox-IN-1 (Compound 52) is an Ape1/Ref-1 redox inhibitor. Ape1/Ref-1 redox-IN-1 can be used in the research of cancer .
loading...
    loading...